Skip to content

NIHR

James Lind Alliance Priority Setting Partnerships

Rolling deadline; no fixed closing date stated

Last updated:

No deadline is on file for this call. Check NIHR's own call page for the current round's status before you plan around it.

Is this grant right for you? Check your personalised match score. 30s, no email. See my matches →

The James Lind Alliance Priority Setting Partnerships rolling call funds hypothesis-driven evaluations of promising clinical interventions aligned with patient and researcher co-identified priorities. Eligible teams must demonstrate proof of concept in humans, secure patient and public involvement from the start, and work across disciplines at UK institutions. This is a domestic NIHR programme open continuously without fixed deadlines.

Details

Funder NIHR
Application 2-stage: outline application → full application
Frequency Continuous
Eligible countries GB

Eligibility & scope

EME Programme rolling call for hypothesis-driven evaluation of promising interventions aligned with James Lind Alliance Priority Setting Partnership priorities. Requires proof of concept in humans, patient/public co-design from outset, and a multidisciplinary team. UK institutions only (domestic programme). Clinical trials must engage an accredited UKCRC CTU.

Who Should Apply

  • Multidisciplinary teams including clinicians, researchers, and patient/public representatives from the outset
  • Applicants based at UK academic medical centres or NHS trusts
  • Interventions with preliminary proof of concept in human settings
  • Projects addressing questions ranked by James Lind Alliance Priority Setting Partnerships
  • Clinical trials must partner with an accredited UKCRC Clinical Trials Unit

Key Dates

  • Rolling deadline: apply at any time with no fixed closing date
  • Two-stage evaluation: outline application → shortlisted teams submit full application and interview
  • Timeline from outline to funding decision varies; check NIHR website for current turnaround

Tips for Applicants

  • Anchor your research question to a James Lind Alliance Priority Setting Partnership output; misalignment with co-identified priorities is a common rejection reason.
  • Patient and public involvement must be embedded in design and team governance from day one, tokenistic consultation in the methods will weaken the outline.
  • If your trial requires a CTU, name the accredited unit and confirm their willingness in the outline; unconfirmed CTU partnerships delay the full application stage.

Frequently Asked Questions

What is the James Lind Alliance Priority Setting Partnership process?

It is a structured collaboration between patients, carers, and researchers to identify and rank unanswered questions in a health condition. NIHR EME funds evaluations that address these co-identified priorities.

Do I need proof of concept before applying to the James Lind Alliance call?

Yes, your intervention must demonstrate proof of concept in humans; early-stage laboratory or animal work alone is not sufficient.

Can international applicants apply to the NIHR EME James Lind Alliance call?

No, this is a domestic UK programme; your institution must be based in the UK.

Is patient involvement optional for the James Lind Alliance Priority Setting Partnership call?

No, patient and public co-design from the outset is mandatory. Patients and the public must be part of the research team, not consulted after design is complete.

How often can I apply to the James Lind Alliance call?

There is no fixed deadline; you can submit an outline application at any time.

nihreme-programmepatient-engagementclinical-trialsuk-domestictranslational-researchmultidisciplinary

Summary generated by AI based on published grant information. Always verify details on the funder's website.

Similar grants

Browse all open grants →

Browse Related

Could James Lind Alliance Priority Setting Partnerships be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →